Close
Xylem
Novotech

Research Insight

Sapio Sciences and Ultima Genomics Partner to Advance Multi-Omics Research

Partnership delivers global, end-to-end solutions to accelerate genomics research Sapio Sciences, the science-awareTMย lab informatics platform, today announced a strategic partnership withย Ultima Genomics. The collaboration will make multi-omics workflows more accessible and streamlined for researchers by integrating Sapioโ€™s AI-powered lab informatics...

Optimizing DMF Quality for Successful Health Authority Filings

A Drug Master File (DMF) is a confidential regulatory submission that provides comprehensive, precise, and accurate data about an Active Pharmaceutical Ingredient (API) or a Finished Product Dosage Form (FP). It encompasses critical information on the manufacturing process, quality...

The Shift Towards Real-World Evidence Clinical Development

The fact remains that the pharmaceutical spectrum happens to stand on the edge of fundamental transformation as the real-world evidence clinical development methods go on to reshape how one gauges the therapeutic intervention. This kind of revolution happens to...

The Way Forward for the Healthcare Data Ecosystem

The transformation of worldwide healthcare by way of digital innovation has reached a very critical inflection point in which the potential advantages of data-driven medicine should be carefully balanced against the fundamental ethical principles as well as privacy rights....

Real-World Data in Managing Pharmaceutical Efficacy-Effectiveness Gap

The pharmaceutical sector stands at a very critical crossroads in which the traditional reliance on randomized control trials (RCTs) alone is no longer sufficient when it comes to comprehensive understanding of drug performance. The Pharmaceutical Efficacy-Effectiveness Gap that the...

Magnetic Particles Steer the Vesicles for Drug Delivery

Researchers have gone on to demonstrate that microscopic drug delivery containers can get magnetically steered to their objectives, thereby advancing the development when it comes to precision medicine for the treatment of diseases like cancer. A multi-university team, which...

Aptar CSP Technologiesโ€™ Dual-Active Material Science Technology Simultaneously Controls Moisture and Oxygen for Pharmaceutical Drugs and Medical Devices

Dual-active material science solution is ideal for sensitive formulations Auburn, AL, July 8, 2025 โ€“ Aptar CSP Technologies, part of AptarGroup, Inc. and a leader in active material science, today announced that it has developed a dual-active material science technology...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป